Ragweed-specific antibodies in bronchoalveolar lavage fluids and serum before and after segmental lung challenge: IgE and IgA associated with eosinophil degranulation

Journal of Allergy and Clinical Immunology

Volumn 101, Issue 2 I, 1998, Pages 265-273

  Peebles Jr , R Stokes ^a,b   Liu, Mark C ^a   Adkinson Jr , N Franklin ^a   Lichtenstein, Lawrence M ^a   Hamilton, Robert G ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Asthma; Bronchoalveolar lavage; Eosinophil; IgA; IgE; Lung; Ragweed

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; MONOCLONAL ANTIBODY;

ADULT; ALLERGIC REACTION; ANTIBODY SPECIFICITY; ARTICLE; ASTHMA; BLOOD VESSEL PERMEABILITY; CELL MIGRATION; CLINICAL ARTICLE; EOSINOPHIL; EPITHELIUM CELL; FEMALE; HUMAN; LUNG LAVAGE; MALE; MAST CELL DEGRANULATION; MEDIATOR RELEASE; PRIORITY JOURNAL; PROVOCATION TEST; RAGWEED;

EID: 0031900945     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(98)70392-6     Document Type: Article

References (30)

1. Liu MC, Hubbard WC, Proud D, Stealey B, Galli S, Kagey-Sobotka A, et al. Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics. Am Rev Respir Dis 1991;144:51-8.
2. Schwartz L, Huff T. Biology of mast cells and basophils. In: Middleton E, Reed C, Ellis E, Adkinson N, Yunginger J, Busse W, editors. Allergy, principles and practice. 4th ed. St. Louis: Mosby; 1993. p. 135-68.
3. 4 in bronchoalveolar lavage fluid from atopic asthmatics after endobronchial allergen challenge. Am Rev Respir Dis 1990;142:112-9.
4. Collins D, Dupuis R, Gleich G, Bartemes K, Koh Y, Pollice M, et al. Immunoglobulin E-mediated increase in vascular permeability correlates with eosinophilic inflammation. Am Rev Respir Dis 1993;147:677-83.
5. Frigas E, Loegering DA, Gleich GJ. Cytotoxic effects of the guinea pig eosinophil major basic protein on tracheal epithelium. Lab Invest 1980;42:35-43.
6. Motojima S, Frigas E, Loegering DA, Gleich GJ. Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro. Am Rev Respir Dis 1989;139:801-5.
7. Gundel RH, Letts LG, Gleich GJ. Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates. J Clin Invest 1991;87:1470-3.
8. Capron M, Spiegelberg HL, Prin L, Bennich H, Butterworth AE, Pierce RJ, et al. Role of IgE receptors in effector function of human eosinophils. J Immunol 1984;132:462-8.
9. Capron M, Kusnierz JP, Prin L, Spiegelberg HL, Ovlaque G, Gosset P, et al. Cytophilic IgE on human blood and tissue eosinophils: detection by flow microfluorometry. J Immunol 1985;134:3013-8.
10. Monteiro R, Hostoffer R, Cooper M, Bonner J, Gartland G, Kubagawa H. Definition of immunoglobulin A receptors on eosinophils and their enhanced expression in allergic individuals. J Clin Invest 1993;92:1681-5.
11. Kaneko M, Jarjour N, Swanson M, Busse W, Gleich G, Kita H. Allergen-specific IgG and IgA in bronchoalveolar lavage fluids from patients with allergy induce eosinophil degranulation [abstract]. J Allergy Clin Immunol 1995;95:339.
12. Lamkhioued B, Gounni A, Gruart V, Pierce A, Capron A, Capron M. Human eosinophils express a receptor for secretory component. Role in secretory IgA-dependent activation. Eur J Immunol 1995;25:117-25.
13. Chai H, Farr R, Froelich L, Mathison D, McLean J, Rosenthal R, et al. Standardization of bronchial inhalational challenge procedures. J Allergy Clin Immunol 1975;56:323-7.
14. Bernstein I. Proceedings of the task force on guidelines for standardizing old and new technologies used for the diagnosis and treatment of allergic diseases. J Allergy Clin Immunol 1988;82:487526.
15. Peebles RS Jr, Liu MC, Lichtenstein LM, Hamilton RG. IgA, IgG and IgM quantification in bronchoalveolar lavage fluids from allergic rhinitics, allergic asthmatics, and normal subjects by monoclonal antibody-based immunoenzymetric assays. J Immunol Methods 1995;179:77-86.
16. Mestecky J, Hamilton RG, Magnusson CGM, Jefferis R, Vaerman JP, Goodall M, et al. Evaluation of monoclonal antibodies with specificity for human IgA, IgA subclasses and all allotypes and secretory components. Results of an IUIS/WHO collaborative study. J Immunol Methods 1996;193:103-48.
17. Hamilton R, Adkinson N Jr. Measurement of total serum immunoglobulin E and allergen-specific immunoglobulin E antibody. In: Rose N, de Macario E, Fahey J, Friedman H, Penn G, editors. Manual of clinical laboratory immunology. 4th ed. Washington (DC): American Society for Microbiology; 1992. p. 689-701.
18. Butler JE, Hamilton RG. Quantitation of specific antibodies: methods of expression, standards, solid phase considerations and specific applications. In: Butler JE, editor. Immunochemistry of solid phase immunoassays. Boca Raton (FL): CRC Press; 1991. p. 173-98.
19. Gordon J, Burd P, Galli S. Mast cells as a source of multifunctional cytokines. Immunol Today 1990;11:458-64.
20. Bradding P, Feather I, Wilson S, Bardin P, Heusser C, Holgate S, et al. Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. J Immunol 1993;151:3852-65.
21. Terada N, Konno A, Tada H, Shirotori K, Ishikawa K, Togawa K. The effect of recombinant human interleukin-5 on eosinophil accumulation and degranulation in human nasal mucosa. J Allergy Clin Immunol 1992;90:160-8.
22. Lopez A, Sanderson C, Gamble J, Campbell H, Young I, Vadas M. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J Exp Med 1988;167:219-24.
23. Clutterbuck E, Hirst E, Sanderson C. Human interleukin 5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6, and GM-CSF. Blood 1988;73:1504-12.
24. Kung T, Stelts D, Zurcher J, Jones H, Umland S, Kreutner W, et al. Mast cells modulate allergic pulmonary eosinophilia in mice. Am J Respir Cell Mol Biol 1995;12:404-9.
25. Kita H, Kaneko M, Frigas E, Bartemes K, Weiler D, Gleich G. Eosinophils from hay fever patients degranulate in response to IgG, but not to IgE [abstract]. J Allergy Clin Immunol 1995;95:339.
26. Fahy JV, Fleming HE, Wong HH, Liu JT, Su JQ, Reimann J, et al. The effect of an anti-IgE monoclonal antibody on the early and late-phase responses to allergen inhalation in asthmatic subjects. Am J Respir Crit Care Med 1997;155:1828-34.
27. Rak S, Bjornson A, Hakanson L, Sorenson S, Venge P. The effect of immunotherapy on eosinophil accumulation and production of eosinophil chemotactic activity in the lung of subjects with asthma during natural pollen exposure. J Allergy Clin Immunol 1991;88:878-88.
28. Abu-Ghazaleh R, Fujisawa T, Mestecky J, Kyle RA, Gleich GJ. IgA-induced eosinophil degranulation. J Immunol 1989;142:2393-400.
29. Adelroth E, Rosenhall L, Johansson S-A, Linden M, Venge P. Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage: the effects of antiasthmatic treatment with budesonide or terbutaline. Am Rev Respir Dis 1990;142:91-9.
30. Venge P. Serum measurements of eosinophil cationic protein (ECP) in bronchial asthma. Clin Exp Allergy 1993;23(Suppl 2):3-7.